Given Prokidney News Today

ProKidney (NASDAQ:PROK – Get Free Report) and Cabaletta Bio (NASDAQ:CABA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk ProKidney has a beta of […]

ProKidney (NASDAQ:PROK – Free Report) is one of 277 public companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare ProKidney to similar businesses based on the strength of its valuation, institutional ownership, analyst recommendations, dividends, risk, earnings and profitability. Analyst Ratings This is a summary […]

ProKidney (NASDAQ:PROK – Get Rating) is one of 281 public companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare ProKidney to related businesses based on the strength of its valuation, institutional ownership, profitability, analyst recommendations, earnings, risk and dividends. Profitability This table compares ProKidney and […]

ProKidney (NASDAQ:PROK – Get Rating) is one of 277 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its competitors? We will compare ProKidney to similar companies based on the strength of its valuation, risk, earnings, analyst recommendations, profitability, dividends and institutional ownership. Insider & Institutional Ownership 14.7% of […]

ProKidney (NASDAQ:PROK – Get Rating) is one of 277 public companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare ProKidney to related companies based on the strength of its profitability, valuation, dividends, risk, institutional ownership, earnings and analyst recommendations. Profitability This table compares ProKidney and […]